Retatrutide Calculator: Dose Units & Reconstitution

Also Check: South Carolina Paycheck Calculator

Retatrutide Dose & Reconstitution Guide: Titration Schedules, Syringe Units, & Weight Loss Math

Retatrutide (LY3437943) is an investigational triple-hormone receptor agonist that targets GLP-1, GIP, and glucagon receptors. Because clinical trials require strict 4-week titration steps to mitigate gastrointestinal side effects, calculating accurate syringe units and tracking schedule dates is critical.

This guide provides the exact clinical trial titration ladders, reconstitution mathematical formulas, syringe unit conversion tables, and projected weight loss metrics.

Investigational Drug Notice: Retatrutide is currently in clinical trials (Eli Lilly’s TRIUMPH program) and is not yet approved by the FDA or international regulatory bodies. Reconstitution applies exclusively to research and clinical preparation settings. Always consult a licensed healthcare provider before making treatment decisions.

How to Use the Retatrutide Calculator

The calculator operates in two specialized modes to handle both scheduling and reconstitution:

• Dose Schedule Mode: Enter your First Injection Date and select your Target Maintenance Dose (4 mg, 9 mg, or 12 mg). The engine maps out your personalized 4-week titration ladder with exact calendar dates for every dose escalation.
• Reconstitution Mode: Enter your Vial Size (mg), the volume of Bacteriostatic (BAC) Water Added (mL), and your Target Dose (mg). The calculator instantly determines the exact number of tick marks (units) to draw on a standard U-100 insulin syringe.

Clinical Titration Schedule (Phase 3 TRIUMPH Protocols)

Clinical trials follow a strict progressive escalation model starting at 2 mg per week. Doses increase every 4 weeks to allow receptor adaptation and minimize nausea, vomiting, or gastrointestinal distress.

Dosing never skips tiers. If an individual targets a 9 mg maintenance level, escalation stops at week 13 without progressing to 12 mg.

Reconstitution Math: Milligrams (mg) to Syringe Units

Lyophilized peptide powder is measured by weight in milligrams (mg), while insulin syringes measure liquid volume in U-100 Units, where:

$$\text{100 Units} = 1.0\text{ mL} \quad \left(1\text{ Unit} = 0.01\text{ mL}\right)$$

Converting powder into injectable syringe units requires a two-step formula:

1. Calculate Solution Concentration

$$\text{Concentration (mg/mL)} = \frac{\text{Vial Size (mg)}}{\text{BAC Water Added (mL)}}$$

2. Calculate Syringe Units to Draw

$$\text{Units to Draw} = \left(\frac{\text{Desired Dose (mg)}}{\text{Concentration (mg/mL)}}\right) \times 100$$

Worked Example:

• Vial Size: 10 mg
• BAC Water Added: 1.0 mL
• Concentration: $10\text{ mg} \div 1.0\text{ mL} = 10\text{ mg/mL}$
• Desired Dose: 2 mg (Week 1 starting dose)
• Calculation: $(2\text{ mg} \div 10\text{ mg/mL}) \times 100 = \mathbf{20\text{ Units}}$ on a U-100 syringe.

Syringe Units Conversion Table (U-100 Syringes)

Use this reference table to find your required draw volume based on common vial sizes and bacteriostatic water combinations:

*Doses exceeding 100 units require more than a full standard 1.0 mL syringe. For higher doses (6 mg–12 mg), use a higher concentration (e.g., 20 mg vial in 1 mL or 2 mL BAC) to keep single injections comfortable and accurate.

Projected Weight Loss by Starting Weight

In Phase 2 and Phase 3 clinical trial data (TRIUMPH-4), participants on the 12 mg maximum dose achieved an average of 28.7% (~29%) total body weight reduction at 68 weeks.

These figures reflect trial population averages alongside dietary and lifestyle interventions; individual metabolic response varies.

Clinical Safety: When to Hold or Delay Dose Escalation

Dose escalation is never mandatory if adverse side effects are present. Prescribers frequently hold patients at their current dose level for an extra 2 to 4 weeks under the following conditions:

• Persistent GI Symptoms: Nausea, vomiting, or reflux lasting longer than 3 consecutive days post-injection.
• Excessive Weight Loss Rate: Losing more than 3 to 4 lbs per week consistently, which increases the risk of gallstones and lean muscle mass depletion.
• Severe Bowel Changes: Prolonged constipation or severe diarrhea causing electrolyte imbalance.
• Dehydration Signs: Dizziness, lightheadedness upon standing, or reduced urine output.

Check our Tools category for more such calculators

Frequently Asked Questions

How many units is 2 mg of Retatrutide?

It depends on the vial concentration. In a standard 10 mg vial reconstituted with 1 mL of BAC water (10 mg/mL), 2 mg is exactly 20 units on a U-100 syringe. If mixed with 2 mL of BAC water (5 mg/mL), 2 mg equals 40 units.

What is the best syringe to use for Retatrutide?

A U-100 insulin syringe with micro-fine needle markings (31G, 5/16″ or 1/2″) is standard. For doses under 50 units (0.5 mL), a 0.5 mL syringe provides the easiest reading precision.

Can I start directly on 4 mg or 6 mg to speed up results?

No. Phase 2 and Phase 3 trial protocols mandate a 2 mg starting dose for the first 4 weeks. Skipping early tiers sharply increases the incidence of severe nausea, vomiting, and treatment discontinuation.

How long does a reconstituted Retatrutide vial remain stable?

Once mixed with bacteriostatic water containing 0.9% benzyl alcohol, vials should be stored protected from light in a refrigerator at 2°C–8°C (36°F–46°F) and used within 28 to 30 days.

Axee Davies

Is a freelance tech writer based in the East Continent, is quite fascinated by modern-day gadgets, smartphones, and all the hype and buzz about modern technology on the Internet. Besides this a part-time photographer and love to travel and explore. Follow me on. Twitter, Facebook Or Simply Contact Here. Or Email: info@axeetech.com

axeetech.com